LCM
MDT icon

Logan Capital Management’s Medtronic MDT Stock Holding History

Logan Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,644
Closed -$1.02M – 426
2025
Q4 		$1.02M Buy
10,644
+23
+0.2% +$2.23K 0.04% 210
2025
Q3 		$1.01M Sell
10,621
-1,838
-15% -$169K 0.04% 211
2025
Q2 		$1.09M Sell
12,459
-10,973
-47% -$931K 0.05% 200
2025
Q1 		$2.11M Sell
23,432
-87,990
-79% -$7.87M 0.1% 169
2024
Q4 		$8.9M Sell
111,422
-6,897
-6% -$597K 0.37% 77
2024
Q3 		$10.7M Sell
118,319
-3,403
-3% -$286K 0.44% 68
2024
Q2 		$9.58M Sell
121,722
-2,122
-2% -$174K 0.41% 72
2024
Q1 		$10.8M Buy
123,844
+16,219
+15% +$1.38M 0.46% 67
2023
Q4 		$8.87M Sell
107,625
-9,478
-8% -$722K 0.41% 74
2023
Q3 		$9.18M Sell
117,103
-6,091
-5% -$510K 0.47% 66
2023
Q2 		$10.9M Buy
123,194
+7,575
+7% +$652K 0.52% 60
2023
Q1 		$9.32M Buy
115,619
+102,769
+800% +$8.38M 0.45% 69
2022
Q4 		$999K Buy
12,850
+791
+7% +$64.1K 0.05% 219
2022
Q3 		$973K Sell
12,059
-39,669
-77% -$3.56M 0.06% 208
2022
Q2 		$4.64M Sell
51,728
-18,056
-26% -$1.83M 0.27% 100
2022
Q1 		$7.74M Buy
69,784
+5,488
+9% +$580K 0.37% 81
2021
Q4 		$6.65M Sell
64,296
-35
-0.1% -$4.05K 0.29% 98
2021
Q3 		$8.06M Buy
64,331
+3,085
+5% +$399K 0.38% 81
2021
Q2 		$7.6M Buy
61,246
+1,717
+3% +$216K 0.35% 85
2021
Q1 		$7.03M Sell
59,529
-2,714
-4% -$318K 0.35% 84
2020
Q4 		$7.29M Buy
62,243
+3,799
+7% +$418K 0.36% 83
2020
Q3 		$6.07M Sell
58,444
-2,333
-4% -$234K 0.33% 87
2020
Q2 		$5.57M Sell
60,777
-237
-0.4% -$22.7K 0.32% 85
2020
Q1 		$5.5M Sell
61,014
-148
-0.2% -$15.7K 0.38% 71
2019
Q4 		$6.94M Sell
61,162
-951
-2% -$104K 0.38% 75
2019
Q3 		$6.75M Buy
62,113
+1,522
+3% +$159K 0.4% 72
2019
Q2 		$5.9M Buy
60,591
+4,708
+8% +$430K 0.35% 82
2019
Q1 		$5.09M Buy
+55,883
New +$5M 0.31% 88
2018
Q1 		– Sell
-2,711
Closed -$219K – 281
2017
Q4 		$219K Sell
2,711
-553
-17% -$44.3K 0.02% 271
2017
Q3 		$254K Buy
3,264
+460
+16% +$38.2K 0.02% 262
2017
Q2 		$249K Buy
2,804
+311
+12% +$26.2K 0.02% 257
2017
Q1 		$201K Sell
2,493
-1,074
-30% -$83.9K 0.02% 265
2016
Q4 		$254K Buy
3,567
+1,229
+53% +$96.6K 0.02% 258
2016
Q3 		$202K Buy
+2,338
New +$204K 0.02% 261
2016
Q2 		– Sell
-16,886
Closed -$1.27M – 280
2016
Q1 		$1.27M Hold
16,886
– – 0.1% 137
2015
Q4 		$1.3M Hold
16,886
– – 0.1% 132
2015
Q3 		$1.13M Hold
16,886
– – 0.09% 137
2015
Q2 		$1.25M Hold
16,886
– – 0.09% 138
2015
Q1 		$1.32M Buy
16,886
+286
+2% +$21.7K 0.09% 132
2014
Q4 		$1.2M Sell
16,600
-2,000
-11% -$139K 0.09% 140
2014
Q3 		$1.15M Hold
18,600
– – 0.08% 132
2014
Q2 		$1.19M Hold
18,600
– – 0.08% 130
2014
Q1 		$1.15M Hold
18,600
– – 0.08% 136
2013
Q4 		$1.07M Hold
18,600
– – 0.08% 147
2013
Q3 		$990K Sell
18,600
-2,110
-10% -$114K 0.07% 143
2013
Q2 		$802K Buy
+20,710
New +$1.02M 0.06% 151

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Logan Capital Management's MDT Position: Q1 2026 in Review

Logan Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 10,644 shares — an estimated $1.02M sold.

Logan Capital Management first reported a position in MDT in Q2 2013 and held it in 46 quarters. The position peaked at $10.9M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Logan Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 10,644 Medtronic shares in Q1 2026, an estimated $1.02M.
  • Logan Capital Management first reported a position in Medtronic in Q2 2013 and held it in 46 quarters.
  • Logan Capital Management's Medtronic position peaked at $10.9M in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.